Publication Name	World Journal of Gastroenterology
Manuscript ID	7281
Country	United States

Received	2013-11-12 14:51
Peer-Review Started	2013-11-13 11:45
To Make the First Decision	2013-12-26 10:49
Return for Revision	2013-12-27 15:08
Revised	2014-01-24 03:18
Second Decision	2014-04-03 10:15
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-04-03 12:33
Articles in Press	2014-05-23 09:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-08-06 11:58
Publish the Manuscript Online	2014-08-20 18:38

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Topic Highlights
Article Title	Cytomegalovirus infection in liver transplant recipients: Updates on clinical management
Manuscript Source	Invited Manuscript
All Author List	Jasmine Riviere Marcelin, Elena Beam and Raymund R Razonable
Funding Agency and Grant Number
Corresponding Author	Raymund R Razonable, MD, Division of Infectious Diseases, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, United States. razonable.raymund@mayo.edu
Key Words	Cytomegalovirus; Liver transplantation; Valganciclovir; Prophylaxis; Treatment; Resistance; Investigational; Letermovir; Brincidofovir
Core Tip	In this article, the authors review the current literature of cytomegalovirus (CMV) infection after liver transplantation, including the approaches to diagnosis, prevention and treatment. The review highlights the pros and cons of the prophylaxis vs pre-emptive prevention strategies, especially in the highest risk D+/R- population. Treatment of CMV infection in liver transplant patients is discussed in addition to management of CMV resistance, with detailed discussion of recently updated clinical CMV management guidelines. Finally, the future management of CMV in liver transplant recipients relies on new drug discoveries, and the authors describe multiple investigational drugs and vaccines in clinical trials.
Publish Date	2014-08-20 18:38
Citation	Marcelin JR, Beam E, Razonable RR. Cytomegalovirus infection in liver transplant recipients: Updates on clinical management. World J Gastroenterol 2014; 20(31): 10658-10667
URL	http://www.wjgnet.com/1007-9327/full/v20/i31/10658.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i31.10658

Full Article (PDF)	WJG-20-10658.pdf
Full Article (Word)	WJG-20-10658.doc
Manuscript File	7281-Review.doc
Answering Reviewers	7281-Answering reviewers.pdf
Copyright License Agreement	7281-Copyright assignment.pdf
Peer-review Report	7281-Peer reviews.pdf
Scientific Editor Work List	7281-Scientific editor work list.doc